Four FTRs and Counting…
BioTeam now has four offerings on the AWS Marketplace, each validated through the AWS Foundational Technical Review (FTR) process. BioTeam has been working with AWS since 2007, when the platform was still in beta. That history runs deep. Over nearly two decades, we have built, migrated, and optimized scientific computing environments for pharma, biotech, federal […]
AI Readiness Assessment and Modernization Roadmap for Biomedical Data Infrastructure
Summary BioTeam partnered with a biomedical research institution within the National Institutes of Health (NIH) to assess its existing data infrastructure and develop a strategic roadmap for integrating artificial intelligence capabilities into its large-scale biomedical data repositories and services. As a steward of globally significant biomedical data resources, the organization sought to ensure its […]
Modernizing Hybrid Infrastructure for Clinical Diagnostics
Summary BioTeam partnered with a prominent clinical diagnostics organization to modernize its digital foundation. This engagement developed a high-level, cloud-smart, modernized strategy for the company’s existing digital backbone, specifically targeting digital image analysis and DNA sequencing to enhance efficiency and oversight and add new diagnostic capabilities. Key strategic recommendations of the project included: Modernize and […]
Initiative Development and Strategic Planning at NIH
Summary The NIH Office of Data Science Strategy (ODSS) sought to support the community development of a standard set of capabilities, services, metrics, and infrastructure across NIH-supported repositories to simplify the sharing and reuse of data. BioTeam oversaw the NIH’s Generalist Repository Ecosystem Initiative (GREI) from its inception through the completion of its first three […]
Modernizing Scientific Infrastructure for Neurodegenerative Research
A leading biotech organization needed a secure, modern, and automated scientific computing foundation to support high-throughput therapeutic discovery for neurodegenerative and lysosomal storage diseases.